About 1 in 8 women in the United States will develop breast cancer at some point in her lifetime. Globally, an estimated 2.3 million women were diagnosed with breast cancer in 2022, making it the most common cancer in women in 157 out of 185 countries. In the U.S. alone, over 42,000 women died from the disease in 2023.
How Common Is Breast Cancer in the U.S.?
Breast cancer is the most frequently diagnosed cancer among American women, excluding skin cancers. The overall incidence rate is roughly 130 new cases per 100,000 women each year, though the number varies by race and ethnicity. Non-Hispanic white women have the highest incidence at about 141 new cases per 100,000, followed by non-Hispanic Black women at 132 per 100,000. Hispanic women have a lower incidence rate of about 108 per 100,000.
To put these numbers in more personal terms: if you gathered 1,000 women at random, roughly 13 of them would be expected to receive a breast cancer diagnosis in a given year. Over a full lifetime, the cumulative risk climbs to approximately 13%, which is where the familiar “1 in 8” figure comes from.
Risk Changes With Age
Breast cancer is uncommon in women under 30. Risk begins to climb meaningfully in the 40s and continues rising through the 60s and 70s, which is the peak decade for diagnosis. The median age at diagnosis in the U.S. is 63, meaning half of all women diagnosed are younger than that and half are older.
This age pattern is one reason screening guidelines generally recommend mammograms starting between ages 40 and 50, depending on individual risk factors. The disease does occur in younger women, but a 30-year-old’s chance of being diagnosed in the next 10 years is far smaller than a 60-year-old’s.
The Global Picture
Worldwide, breast cancer accounted for an estimated 2.3 million new diagnoses and 670,000 deaths in 2022, according to the World Health Organization. It is the leading cancer diagnosis among women in the vast majority of countries. Incidence rates tend to be higher in high-income countries, partly because of screening that catches cancers earlier, and partly because of lifestyle factors like later age at first pregnancy, fewer pregnancies overall, and higher rates of obesity.
Mortality, however, is disproportionately concentrated in lower-income countries, where access to early detection and treatment is more limited. A woman diagnosed in sub-Saharan Africa faces a much worse prognosis than a woman diagnosed at the same stage in the U.S. or Western Europe.
Racial Disparities in the U.S.
While non-Hispanic white women are diagnosed at the highest rate, non-Hispanic Black women die from breast cancer at a significantly higher rate. The death rate among Black women is about 25.9 per 100,000, compared to 19.1 per 100,000 for white women. That gap, roughly 36% higher mortality, persists even though the incidence rates are relatively close.
Several factors drive this disparity. Black women are more likely to be diagnosed with aggressive tumor types, particularly triple-negative breast cancer, which is harder to treat. Delays in diagnosis and treatment, often tied to insurance status and access to care, also contribute. Hispanic and Asian/Pacific Islander women have both lower incidence and lower mortality rates, at 13.4 and 11.8 deaths per 100,000 respectively.
Survival Rates by Stage
The earlier breast cancer is caught, the better the outlook. Five-year relative survival rates from the National Cancer Institute break down clearly by how far the cancer has spread at the time of diagnosis:
- Localized (cancer is only in the breast): 99.3% five-year survival
- Regional (cancer has spread to nearby lymph nodes): 86.3% five-year survival
- Distant (cancer has metastasized to other parts of the body): 31% five-year survival
The vast majority of breast cancers in the U.S. are caught at the localized or regional stage, which is why the overall five-year survival rate is high. These numbers represent averages across all women diagnosed between 2013 and 2019, so they reflect treatments that may already be a few years old. Newer therapies, particularly for advanced disease, continue to improve outcomes.
What Affects Your Individual Risk
The 1-in-8 lifetime figure is an average across all women, but individual risk varies considerably. The strongest risk factor is age. Family history matters too: having a first-degree relative (mother, sister, or daughter) with breast cancer roughly doubles your risk, though most women who develop breast cancer have no family history at all.
Inherited gene mutations, most notably in BRCA1 and BRCA2, carry a much higher lifetime risk, sometimes 60% or more. But these mutations account for only about 5 to 10% of all breast cancer cases. For the remaining 90-plus percent, a combination of hormonal exposure, body weight, alcohol use, physical activity, and reproductive history shapes risk. Women who had their first period before age 12, entered menopause after 55, or never had children tend to face slightly higher risk because of longer cumulative exposure to estrogen.
Modifiable factors make a real difference at the population level. Regular physical activity, maintaining a healthy weight after menopause, and limiting alcohol to no more than one drink per day are each associated with meaningful reductions in risk. None of these eliminate the possibility of a diagnosis, but they shift the odds.